The latest price target for Sotera Health (NASDAQ:SHC) was reported by Barclays on February 18, 2025. The analyst firm set a price target for $17.00 expecting SHC to rise to within 12 months (a possible 38.44% upside). 11 analyst firms have reported ratings in the last year.

The latest analyst rating for Sotera Health (NASDAQ:SHC) was provided by Barclays, and Sotera Health maintained their overweight rating.

The last upgrade for Sotera Health Co happened on April 3, 2024 when Citigroup raised their price target to $16. Citigroup previously had a neutral for Sotera Health Co.

The last downgrade for Sotera Health Co happened on November 16, 2022 when Barclays changed their price target from $7 to $6 for Sotera Health Co.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sotera Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sotera Health was filed on February 18, 2025 so you should expect the next rating to be made available sometime around February 18, 2026.

While ratings are subjective and will change, the latest Sotera Health (SHC) rating was a maintained with a price target of $18.00 to $17.00. The current price Sotera Health (SHC) is trading at is $12.28, which is out of the analyst’s predicted range.